Differential effects of N-peptidyl-O-acyl hydroxylamines on dynorphin-induced antinociception in the mouse capsaicin test

Neuropeptides

Volumn 39, Issue 6, 2005, Pages 569-573

  Tan No, Koichi ^a   Taira, Aki ^a   Nakagawasai, Osamu ^a   Niijima, Fukie ^a   Demuth, Hans Ulrich ^b   Silberring, Jerzy ^c   Terenius, Lars ^d   Tadano, Takeshi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b PROBIODRUG AG   (Germany)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Capsaicin test; Cysteine proteases; Dynorphins; Intrathecal administration; Mouse; N peptidyl O acyl hydroxylamines

Indexed keywords

CAPSAICIN; CYSTEINE PROTEINASE INHIBITOR; DYNORPHIN; DYNORPHIN A; DYNORPHIN B; HYDROXYMERCURIBENZOIC ACID; N PEPTIDYL O ACYLHYDROXYLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HINDLIMB; INJECTION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; SPINAL CORD; TIME; TISSUE SPECIFICITY;

ANALGESICS; ANIMALS; CAPSAICIN; DYNORPHINS; ENDORPHINS; HUMANS; HYDROXYLAMINES; HYDROXYMERCURIBENZOATES; INJECTIONS, SPINAL; MALE; MICE; PAIN MEASUREMENT; PROTEASE INHIBITORS;

ANIMALIA;

EID: 28344440543     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2005.09.004     Document Type: Article

References (17)

1. D. Brömme, A. Schierhorn, H. Kirschke, B. Wiederanders, A. Barth, S. Fittkau, and H.-U. Demuth Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines Biochemical Journal 263 1989 861 866
2. H.-U. Demuth, J. Silberring, and F. Nyberg Inhibition of proteases with enkephalin-analogue inhibitors Journal of Enzyme Inhibition 4 1991 289 298
3. 5]enkephalin from dynorphin A (1-8) by rat central nervous tissue in vitro Journal of Neurochemistry 54 1990 1379 1385
4. V. Höllt Opioid peptide processing and receptor selectivity Annual Review of Pharmacology and Toxicology 26 1986 59 77
5. J.L.K. Hylden, and G.L. Wilcox Intrathecal morphine in mice, a new technique European Journal of Pharmacology 67 1980 313 316
6. H. Khachaturian, S.J. Watoson, M.E. Lewis, D. Coy, A. Goldstein, and H. Akil Dynorphin immunocytochemistry in the rat central nervous system Peptides 3 1982 941 954
7. J.T. Litchfield, and F. Wilcoxon A simplified method of evaluating dose-effect experiment Journal of Pharmacology and Experimental Therapeutics 96 1949 99 113
8. K. Ploj, E. Roman, L. Gustavsson, and I. Nylander Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice Brain Research Bulletin 53 2000 219 226
9. T. Sakurada, K. Katsumata, K. Tan-No, S. Sakurada, and K. Kisara The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord Neuropharmacology 31 1992 1279 1285
10. J. Silberring, and F. Nyberg A novel bovine spinal cord endoprotease with high specificity for dynorphin B Journal of Biological Chemistry 264 1989 11082 11086
11. J. Silberring, M.E. Castello, and F. Nyberg Characterization of dynorphin A-converting enzyme in human spinal cord. An endoprotease related to a distinct conversion pathway for the opioid heptadecapeptide? Journal of Biological Chemistry 267 1992 21324 21328
12. J. Silberring, H.-U. Demuth, P. Brostedt, and F. Nyberg Inhibition of dynorphin converting enzymes from human spinal cord by N-peptidyl-O-acyl hydroxylamines Journal of Biochemistry 114 1993 648 651
13. K. Tan-No, A. Taira, T. Sakurada, M. Inoue, S. Sakurada, T. Tadano, T. Sato, C. Sakurada, I. Nylander, J. Silberring, L. Terenius, and K. Kisara Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test European Journal of Pharmacology 314 1996 61 67
14. K. Tan-No, L. Terenius, J. Silberring, and I. Nylander Levels of dynorphin peptides in the central nervous system and pituitary gland of the spontaneously hypertensive rat Neurochemistry International 31 1997 27 32
15. K. Tan-No, A. Taira, M. Inoue, K. Ohshima, T. Sakurada, C. Sakurada, I. Nylander, H.-U. Demuth, J. Silberring, L. Terenius, T. Tadano, and K. Kisara Intrathecal administration of p-hydroxymercuribenzoate or phosphoramidon/ bestatin-combined induces antinociceptive effects through different opioid mechanisms Neuropeptides 32 1998 411 415
16. K. Tan-No, K. Ohshima, A. Taira, M. Inoue, F. Niijima, O. Nakagawasai, T. Tadano, I. Nylander, J. Silberring, L. Terenius, and K. Kisara Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test Brain Research 891 2001 274 280
17. K. Tan-No, H. Takahashi, O. Nakagawasai, F. Niijima, T. Sato, S. Satoh, S. Sakurada, Z. Marinova, T. Yakovleva, G. Bakalkin, L. Terenius, and T. Tadano Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation Pain 113 2005 301 309